nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.35	1	CbGbCtD
Selegiline—Intentional injury—Riluzole—amyotrophic lateral sclerosis	0.029	0.0477	CcSEcCtD
Selegiline—Prostate carcinoma—Riluzole—amyotrophic lateral sclerosis	0.0256	0.0422	CcSEcCtD
Selegiline—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0229	CcSEcCtD
Selegiline—Personality change—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0208	CcSEcCtD
Selegiline—Prostate cancer—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0208	CcSEcCtD
Selegiline—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.012	0.0198	CcSEcCtD
Selegiline—Subdural haematoma—Riluzole—amyotrophic lateral sclerosis	0.0115	0.019	CcSEcCtD
Selegiline—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00741	0.0122	CcSEcCtD
Selegiline—Trismus—Riluzole—amyotrophic lateral sclerosis	0.00723	0.0119	CcSEcCtD
Selegiline—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00648	0.0107	CcSEcCtD
Selegiline—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0101	CcSEcCtD
Selegiline—Yawning—Riluzole—amyotrophic lateral sclerosis	0.006	0.00988	CcSEcCtD
Selegiline—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00589	0.0097	CcSEcCtD
Selegiline—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00578	0.00953	CcSEcCtD
Selegiline—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00936	CcSEcCtD
Selegiline—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00936	CcSEcCtD
Selegiline—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00558	0.0092	CcSEcCtD
Selegiline—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00849	CcSEcCtD
Selegiline—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00849	CcSEcCtD
Selegiline—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.005	0.00823	CcSEcCtD
Selegiline—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00811	CcSEcCtD
Selegiline—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00485	0.008	CcSEcCtD
Selegiline—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00485	0.008	CcSEcCtD
Selegiline—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00788	CcSEcCtD
Selegiline—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00757	CcSEcCtD
Selegiline—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00757	CcSEcCtD
Selegiline—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00442	0.00728	CcSEcCtD
Selegiline—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00436	0.00719	CcSEcCtD
Selegiline—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00431	0.0071	CcSEcCtD
Selegiline—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00701	CcSEcCtD
Selegiline—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00426	0.00701	CcSEcCtD
Selegiline—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00693	CcSEcCtD
Selegiline—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00669	CcSEcCtD
Selegiline—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00661	CcSEcCtD
Selegiline—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00654	CcSEcCtD
Selegiline—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00633	CcSEcCtD
Selegiline—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00613	CcSEcCtD
Selegiline—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00607	CcSEcCtD
Selegiline—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00607	CcSEcCtD
Selegiline—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00589	CcSEcCtD
Selegiline—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00584	CcSEcCtD
Selegiline—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00584	CcSEcCtD
Selegiline—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00584	CcSEcCtD
Selegiline—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00567	CcSEcCtD
Selegiline—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00562	CcSEcCtD
Selegiline—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00562	CcSEcCtD
Selegiline—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00557	CcSEcCtD
Selegiline—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00557	CcSEcCtD
Selegiline—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00552	CcSEcCtD
Selegiline—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00335	0.00552	CcSEcCtD
Selegiline—Mania—Riluzole—amyotrophic lateral sclerosis	0.00332	0.00547	CcSEcCtD
Selegiline—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00533	CcSEcCtD
Selegiline—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00528	CcSEcCtD
Selegiline—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00528	CcSEcCtD
Selegiline—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00321	0.00528	CcSEcCtD
Selegiline—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00315	0.0052	CcSEcCtD
Selegiline—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00515	CcSEcCtD
Selegiline—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00511	CcSEcCtD
Selegiline—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.003	0.00495	CcSEcCtD
Selegiline—Myocardial ischaemia—Riluzole—amyotrophic lateral sclerosis	0.003	0.00495	CcSEcCtD
Selegiline—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00491	CcSEcCtD
Selegiline—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00484	CcSEcCtD
Selegiline—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00484	CcSEcCtD
Selegiline—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00463	CcSEcCtD
Selegiline—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00456	CcSEcCtD
Selegiline—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00453	CcSEcCtD
Selegiline—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00273	0.0045	CcSEcCtD
Selegiline—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00444	CcSEcCtD
Selegiline—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00441	CcSEcCtD
Selegiline—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00438	CcSEcCtD
Selegiline—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00438	CcSEcCtD
Selegiline—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00435	CcSEcCtD
Selegiline—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00435	CcSEcCtD
Selegiline—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00432	CcSEcCtD
Selegiline—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.0026	0.00429	CcSEcCtD
Selegiline—Gout—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00426	CcSEcCtD
Selegiline—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00423	CcSEcCtD
Selegiline—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00421	CcSEcCtD
Selegiline—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00421	CcSEcCtD
Selegiline—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00418	CcSEcCtD
Selegiline—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00408	CcSEcCtD
Selegiline—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00405	CcSEcCtD
Selegiline—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00403	CcSEcCtD
Selegiline—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00398	CcSEcCtD
Selegiline—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00398	CcSEcCtD
Selegiline—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00393	CcSEcCtD
Selegiline—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00393	CcSEcCtD
Selegiline—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00236	0.00389	CcSEcCtD
Selegiline—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00384	CcSEcCtD
Selegiline—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00231	0.0038	CcSEcCtD
Selegiline—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00378	CcSEcCtD
Selegiline—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00366	CcSEcCtD
Selegiline—Coma—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00364	CcSEcCtD
Selegiline—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0036	CcSEcCtD
Selegiline—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00218	0.0036	CcSEcCtD
Selegiline—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00354	CcSEcCtD
Selegiline—MAOB—nerve—amyotrophic lateral sclerosis	0.00215	0.088	CbGeAlD
Selegiline—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00349	CcSEcCtD
Selegiline—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00345	CcSEcCtD
Selegiline—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00342	CcSEcCtD
Selegiline—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00339	CcSEcCtD
Selegiline—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00339	CcSEcCtD
Selegiline—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00332	CcSEcCtD
Selegiline—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00332	CcSEcCtD
Selegiline—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.002	0.00329	CcSEcCtD
Selegiline—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00323	CcSEcCtD
Selegiline—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00321	CcSEcCtD
Selegiline—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00318	CcSEcCtD
Selegiline—Injury—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00314	CcSEcCtD
Selegiline—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00311	CcSEcCtD
Selegiline—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00307	CcSEcCtD
Selegiline—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00307	CcSEcCtD
Selegiline—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00305	CcSEcCtD
Selegiline—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00303	CcSEcCtD
Selegiline—MAOA—nerve—amyotrophic lateral sclerosis	0.00183	0.0751	CbGeAlD
Selegiline—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00297	CcSEcCtD
Selegiline—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0029	CcSEcCtD
Selegiline—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00289	CcSEcCtD
Selegiline—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00289	CcSEcCtD
Selegiline—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00289	CcSEcCtD
Selegiline—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00287	CcSEcCtD
Selegiline—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00284	CcSEcCtD
Selegiline—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00284	CcSEcCtD
Selegiline—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00282	CcSEcCtD
Selegiline—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00279	CcSEcCtD
Selegiline—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00275	CcSEcCtD
Selegiline—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00275	CcSEcCtD
Selegiline—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00274	CcSEcCtD
Selegiline—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00272	CcSEcCtD
Selegiline—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00269	CcSEcCtD
Selegiline—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00267	CcSEcCtD
Selegiline—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00161	0.0659	CbGeAlD
Selegiline—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00264	CcSEcCtD
Selegiline—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00263	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00158	0.0026	CcSEcCtD
Selegiline—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00256	CcSEcCtD
Selegiline—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00255	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00255	CcSEcCtD
Selegiline—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0025	CcSEcCtD
Selegiline—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0025	CcSEcCtD
Selegiline—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0025	CcSEcCtD
Selegiline—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00243	CcSEcCtD
Selegiline—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0024	CcSEcCtD
Selegiline—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00233	CcSEcCtD
Selegiline—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00231	CcSEcCtD
Selegiline—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0023	CcSEcCtD
Selegiline—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00228	CcSEcCtD
Selegiline—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00227	CcSEcCtD
Selegiline—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00137	0.0562	CbGeAlD
Selegiline—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00226	CcSEcCtD
Selegiline—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00224	CcSEcCtD
Selegiline—Depression—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00222	CcSEcCtD
Selegiline—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00219	CcSEcCtD
Selegiline—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00218	CcSEcCtD
Selegiline—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00218	CcSEcCtD
Selegiline—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00217	CcSEcCtD
Selegiline—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00216	CcSEcCtD
Selegiline—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00213	CcSEcCtD
Selegiline—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00212	CcSEcCtD
Selegiline—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00211	CcSEcCtD
Selegiline—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00127	0.0021	CcSEcCtD
Selegiline—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00209	CcSEcCtD
Selegiline—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00203	CcSEcCtD
Selegiline—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00122	0.002	CcSEcCtD
Selegiline—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.002	CcSEcCtD
Selegiline—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00199	CcSEcCtD
Selegiline—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00199	CcSEcCtD
Selegiline—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00198	CcSEcCtD
Selegiline—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00197	CcSEcCtD
Selegiline—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00197	CcSEcCtD
Selegiline—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00196	CcSEcCtD
Selegiline—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00181	CcSEcCtD
Selegiline—Chills—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00179	CcSEcCtD
Selegiline—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00178	CcSEcCtD
Selegiline—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00177	CcSEcCtD
Selegiline—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00175	CcSEcCtD
Selegiline—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00174	CcSEcCtD
Selegiline—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00171	CcSEcCtD
Selegiline—Tension—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00171	CcSEcCtD
Selegiline—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0017	CcSEcCtD
Selegiline—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00169	CcSEcCtD
Selegiline—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00168	CcSEcCtD
Selegiline—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00167	CcSEcCtD
Selegiline—MAOB—embryo—amyotrophic lateral sclerosis	0.00101	0.0412	CbGeAlD
Selegiline—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000989	0.00163	CcSEcCtD
Selegiline—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000979	0.00161	CcSEcCtD
Selegiline—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000976	0.00161	CcSEcCtD
Selegiline—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00097	0.0016	CcSEcCtD
Selegiline—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00157	CcSEcCtD
Selegiline—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000948	0.00156	CcSEcCtD
Selegiline—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00156	CcSEcCtD
Selegiline—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000945	0.00156	CcSEcCtD
Selegiline—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00154	CcSEcCtD
Selegiline—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000928	0.00153	CcSEcCtD
Selegiline—MAOB—brainstem—amyotrophic lateral sclerosis	0.000922	0.0378	CbGeAlD
Selegiline—Cough—Riluzole—amyotrophic lateral sclerosis	0.000921	0.00152	CcSEcCtD
Selegiline—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000915	0.00151	CcSEcCtD
Selegiline—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000911	0.0015	CcSEcCtD
Selegiline—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00148	CcSEcCtD
Selegiline—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00148	CcSEcCtD
Selegiline—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000899	0.00148	CcSEcCtD
Selegiline—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00148	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000893	0.00147	CcSEcCtD
Selegiline—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00146	CcSEcCtD
Selegiline—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000879	0.00145	CcSEcCtD
Selegiline—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000869	0.00143	CcSEcCtD
Selegiline—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000862	0.00142	CcSEcCtD
Selegiline—MAOA—embryo—amyotrophic lateral sclerosis	0.000859	0.0352	CbGeAlD
Selegiline—Infection—Riluzole—amyotrophic lateral sclerosis	0.000856	0.00141	CcSEcCtD
Selegiline—Shock—Riluzole—amyotrophic lateral sclerosis	0.000848	0.0014	CcSEcCtD
Selegiline—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000845	0.00139	CcSEcCtD
Selegiline—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000844	0.00139	CcSEcCtD
Selegiline—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00139	CcSEcCtD
Selegiline—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000837	0.00138	CcSEcCtD
Selegiline—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000833	0.00137	CcSEcCtD
Selegiline—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000821	0.00135	CcSEcCtD
Selegiline—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000816	0.0334	CbGeAlD
Selegiline—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00133	CcSEcCtD
Selegiline—MAOA—brainstem—amyotrophic lateral sclerosis	0.000787	0.0322	CbGeAlD
Selegiline—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000785	0.00129	CcSEcCtD
Selegiline—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00128	CcSEcCtD
Selegiline—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000774	0.00127	CcSEcCtD
Selegiline—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000768	0.00127	CcSEcCtD
Selegiline—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000766	0.00126	CcSEcCtD
Selegiline—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00125	CcSEcCtD
Selegiline—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000749	0.00123	CcSEcCtD
Selegiline—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000744	0.00123	CcSEcCtD
Selegiline—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000743	0.00122	CcSEcCtD
Selegiline—Pain—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00121	CcSEcCtD
Selegiline—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00121	CcSEcCtD
Selegiline—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00071	0.00117	CcSEcCtD
Selegiline—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00116	CcSEcCtD
Selegiline—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000684	0.00113	CcSEcCtD
Selegiline—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00112	CcSEcCtD
Selegiline—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00112	CcSEcCtD
Selegiline—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.000643	0.0263	CbGeAlD
Selegiline—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00105	CcSEcCtD
Selegiline—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000618	0.00102	CcSEcCtD
Selegiline—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000616	0.0252	CbGeAlD
Selegiline—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00061	0.001	CcSEcCtD
Selegiline—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000589	0.000971	CcSEcCtD
Selegiline—MAOB—spinal cord—amyotrophic lateral sclerosis	0.000574	0.0235	CbGeAlD
Selegiline—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00057	0.000939	CcSEcCtD
Selegiline—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.000549	0.0225	CbGeAlD
Selegiline—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000548	0.000903	CcSEcCtD
Selegiline—Rash—Riluzole—amyotrophic lateral sclerosis	0.000543	0.000895	CcSEcCtD
Selegiline—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000543	0.000894	CcSEcCtD
Selegiline—Headache—Riluzole—amyotrophic lateral sclerosis	0.00054	0.000889	CcSEcCtD
Selegiline—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000512	0.000843	CcSEcCtD
Selegiline—CYP2A6—brain—amyotrophic lateral sclerosis	0.000501	0.0205	CbGeAlD
Selegiline—MAOA—spinal cord—amyotrophic lateral sclerosis	0.000489	0.02	CbGeAlD
Selegiline—MAOB—nervous system—amyotrophic lateral sclerosis	0.000483	0.0198	CbGeAlD
Selegiline—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000468	0.0192	CbGeAlD
Selegiline—MAOB—central nervous system—amyotrophic lateral sclerosis	0.000465	0.0191	CbGeAlD
Selegiline—MAOB—cerebellum—amyotrophic lateral sclerosis	0.000455	0.0186	CbGeAlD
Selegiline—MAOA—nervous system—amyotrophic lateral sclerosis	0.000412	0.0169	CbGeAlD
Selegiline—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000412	0.0169	CbGeAlD
Selegiline—MAOA—central nervous system—amyotrophic lateral sclerosis	0.000397	0.0163	CbGeAlD
Selegiline—MAOA—cerebellum—amyotrophic lateral sclerosis	0.000388	0.0159	CbGeAlD
Selegiline—MAOB—brain—amyotrophic lateral sclerosis	0.000369	0.0151	CbGeAlD
Selegiline—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000367	0.015	CbGeAlD
Selegiline—ABCB1—embryo—amyotrophic lateral sclerosis	0.000367	0.015	CbGeAlD
Selegiline—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00033	0.0135	CbGeAlD
Selegiline—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000317	0.013	CbGeAlD
Selegiline—MAOA—brain—amyotrophic lateral sclerosis	0.000315	0.0129	CbGeAlD
Selegiline—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000309	0.0127	CbGeAlD
Selegiline—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000298	0.0122	CbGeAlD
Selegiline—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000291	0.0119	CbGeAlD
Selegiline—CYP2C8—brain—amyotrophic lateral sclerosis	0.000281	0.0115	CbGeAlD
Selegiline—CYP2B6—brain—amyotrophic lateral sclerosis	0.000252	0.0103	CbGeAlD
Selegiline—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000249	0.0102	CbGeAlD
Selegiline—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000245	0.01	CbGeAlD
Selegiline—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00024	0.00982	CbGeAlD
Selegiline—CYP2E1—brain—amyotrophic lateral sclerosis	0.000237	0.00969	CbGeAlD
Selegiline—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000236	0.00966	CbGeAlD
Selegiline—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000235	0.00961	CbGeAlD
Selegiline—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000231	0.00944	CbGeAlD
Selegiline—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000209	0.00857	CbGeAlD
Selegiline—CYP2D6—brain—amyotrophic lateral sclerosis	0.000187	0.00767	CbGeAlD
Selegiline—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000176	0.00722	CbGeAlD
Selegiline—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.00017	0.00695	CbGeAlD
Selegiline—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000166	0.00679	CbGeAlD
Selegiline—ABCB1—brain—amyotrophic lateral sclerosis	0.000135	0.00552	CbGeAlD
Selegiline—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	7.72e-05	0.00403	CbGpPWpGaD
Selegiline—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.37e-05	0.00385	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	7.31e-05	0.00382	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	7.2e-05	0.00376	CbGpPWpGaD
Selegiline—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.18e-05	0.00375	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	6.91e-05	0.00361	CbGpPWpGaD
Selegiline—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.91e-05	0.00361	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	6.8e-05	0.00355	CbGpPWpGaD
Selegiline—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	6.75e-05	0.00352	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.73e-05	0.00351	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.67e-05	0.00348	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.31e-05	0.00329	CbGpPWpGaD
Selegiline—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.3e-05	0.00329	CbGpPWpGaD
Selegiline—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	6.2e-05	0.00324	CbGpPWpGaD
Selegiline—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	6.12e-05	0.00319	CbGpPWpGaD
Selegiline—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	6.1e-05	0.00319	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.77e-05	0.00301	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.7e-05	0.00297	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.63e-05	0.00294	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	5.47e-05	0.00285	CbGpPWpGaD
Selegiline—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.37e-05	0.0028	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.36e-05	0.0028	CbGpPWpGaD
Selegiline—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	5.3e-05	0.00277	CbGpPWpGaD
Selegiline—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	5.3e-05	0.00277	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.15e-05	0.00269	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.13e-05	0.00268	CbGpPWpGaD
Selegiline—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.1e-05	0.00266	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.04e-05	0.00263	CbGpPWpGaD
Selegiline—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	4.85e-05	0.00253	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	4.83e-05	0.00252	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.79e-05	0.0025	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	4.75e-05	0.00248	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.7e-05	0.00245	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	4.63e-05	0.00241	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	4.61e-05	0.00241	CbGpPWpGaD
Selegiline—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.56e-05	0.00238	CbGpPWpGaD
Selegiline—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.51e-05	0.00235	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.5e-05	0.00235	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.4e-05	0.0023	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.39e-05	0.00229	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.37e-05	0.00228	CbGpPWpGaD
Selegiline—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	4.36e-05	0.00228	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	4.34e-05	0.00227	CbGpPWpGaD
Selegiline—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.33e-05	0.00226	CbGpPWpGaD
Selegiline—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.27e-05	0.00223	CbGpPWpGaD
Selegiline—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	4.27e-05	0.00223	CbGpPWpGaD
Selegiline—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.24e-05	0.00221	CbGpPWpGaD
Selegiline—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	4.24e-05	0.00221	CbGpPWpGaD
Selegiline—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.18e-05	0.00218	CbGpPWpGaD
Selegiline—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.15e-05	0.00217	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	4.11e-05	0.00215	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	4.11e-05	0.00215	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.1e-05	0.00214	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.01e-05	0.00209	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	3.96e-05	0.00207	CbGpPWpGaD
Selegiline—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	3.83e-05	0.002	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	3.79e-05	0.00198	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.76e-05	0.00196	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	3.73e-05	0.00195	CbGpPWpGaD
Selegiline—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.67e-05	0.00191	CbGpPWpGaD
Selegiline—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.62e-05	0.00189	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	3.6e-05	0.00188	CbGpPWpGaD
Selegiline—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.55e-05	0.00185	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.51e-05	0.00183	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	3.51e-05	0.00183	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.5e-05	0.00183	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.46e-05	0.0018	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	3.35e-05	0.00175	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.32e-05	0.00173	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.32e-05	0.00173	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.29e-05	0.00172	CbGpPWpGaD
Selegiline—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.27e-05	0.00171	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.25e-05	0.0017	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.25e-05	0.0017	CbGpPWpGaD
Selegiline—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.23e-05	0.00168	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.09e-05	0.00161	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.05e-05	0.00159	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.04e-05	0.00158	CbGpPWpGaD
Selegiline—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.01e-05	0.00157	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	2.99e-05	0.00156	CbGpPWpGaD
Selegiline—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.98e-05	0.00156	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	2.97e-05	0.00155	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.97e-05	0.00155	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.97e-05	0.00155	CbGpPWpGaD
Selegiline—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.94e-05	0.00154	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	2.9e-05	0.00152	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	2.86e-05	0.00149	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	2.83e-05	0.00148	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.82e-05	0.00147	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.81e-05	0.00147	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	2.81e-05	0.00147	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	2.81e-05	0.00147	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	2.81e-05	0.00146	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.76e-05	0.00144	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	2.7e-05	0.00141	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	2.68e-05	0.0014	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.65e-05	0.00138	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.62e-05	0.00137	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.6e-05	0.00136	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.57e-05	0.00134	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	2.55e-05	0.00133	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.55e-05	0.00133	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.52e-05	0.00131	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.51e-05	0.00131	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.51e-05	0.00131	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	2.45e-05	0.00128	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	2.45e-05	0.00128	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	2.43e-05	0.00127	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.4e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.4e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.39e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	2.35e-05	0.00123	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.34e-05	0.00122	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.31e-05	0.0012	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.31e-05	0.0012	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.29e-05	0.0012	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.29e-05	0.00119	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.29e-05	0.00119	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.25e-05	0.00118	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.25e-05	0.00117	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.24e-05	0.00117	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	2.2e-05	0.00115	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.17e-05	0.00113	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.17e-05	0.00113	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.13e-05	0.00111	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.13e-05	0.00111	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.11e-05	0.0011	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.09e-05	0.00109	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.08e-05	0.00109	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	2.08e-05	0.00109	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.03e-05	0.00106	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2e-05	0.00105	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	1.97e-05	0.00103	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.96e-05	0.00102	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	1.96e-05	0.00102	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	1.95e-05	0.00102	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	1.95e-05	0.00102	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.94e-05	0.00101	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	1.94e-05	0.00101	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	1.93e-05	0.00101	CbGpPWpGaD
Selegiline—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.88e-05	0.000984	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	1.84e-05	0.000962	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	1.84e-05	0.000958	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	1.83e-05	0.000954	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.82e-05	0.000951	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.000949	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	1.81e-05	0.000946	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.79e-05	0.000933	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.78e-05	0.00093	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	1.77e-05	0.000924	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.73e-05	0.000904	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.71e-05	0.000891	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.68e-05	0.000876	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.67e-05	0.00087	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.66e-05	0.000867	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.65e-05	0.000863	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	1.64e-05	0.000858	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.56e-05	0.000815	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.54e-05	0.000803	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	1.52e-05	0.000794	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.51e-05	0.000787	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.51e-05	0.000787	CbGpPWpGaD
Selegiline—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	1.42e-05	0.000744	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.42e-05	0.000741	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.41e-05	0.000737	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.41e-05	0.000737	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.38e-05	0.00072	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.38e-05	0.000719	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.37e-05	0.000717	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.35e-05	0.000704	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.34e-05	0.0007	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.29e-05	0.000675	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.28e-05	0.000669	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.27e-05	0.000662	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-05	0.00066	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.25e-05	0.000654	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.24e-05	0.000646	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.21e-05	0.000629	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.2e-05	0.000626	CbGpPWpGaD
Selegiline—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.18e-05	0.000617	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.17e-05	0.000609	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.17e-05	0.000609	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.16e-05	0.000603	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.15e-05	0.000603	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.09e-05	0.000569	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.09e-05	0.000567	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.07e-05	0.000559	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.06e-05	0.000556	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	0.00055	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.04e-05	0.000544	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.02e-05	0.00053	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	9.88e-06	0.000516	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.76e-06	0.00051	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	9.58e-06	0.0005	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.5e-06	0.000496	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	9.5e-06	0.000496	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.18e-06	0.000479	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	9.06e-06	0.000473	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9e-06	0.00047	CbGpPWpGaD
Selegiline—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	8.94e-06	0.000467	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.66e-06	0.000452	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.44e-06	0.00044	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	8.26e-06	0.000431	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.11e-06	0.000423	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	7.63e-06	0.000398	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.41e-06	0.000387	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.4e-06	0.000386	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.29e-06	0.000381	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.25e-06	0.000379	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	6.94e-06	0.000362	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.81e-06	0.000355	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.67e-06	0.000348	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.51e-06	0.00034	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.27e-06	0.000327	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.26e-06	0.000327	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.13e-06	0.00032	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.94e-06	0.00031	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.76e-06	0.000301	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	5.6e-06	0.000292	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.6e-06	0.000292	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	5.49e-06	0.000286	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.46e-06	0.000285	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.15e-06	0.000269	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.14e-06	0.000268	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.1e-06	0.000266	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.07e-06	0.000265	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.02e-06	0.000262	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.76e-06	0.000248	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	4.74e-06	0.000247	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.73e-06	0.000247	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.69e-06	0.000245	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.36e-06	0.000228	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.23e-06	0.000221	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	4.13e-06	0.000216	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.01e-06	0.000209	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.89e-06	0.000203	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	3.86e-06	0.000201	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.84e-06	0.0002	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.76e-06	0.000196	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.37e-06	0.000176	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.3e-06	0.000172	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.25e-06	0.00017	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.09e-06	0.000161	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.9e-06	0.000151	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.83e-06	0.000148	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.67e-06	0.000139	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.64e-06	0.000138	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.54e-06	0.000133	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.26e-06	0.000118	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.74e-06	9.1e-05	CbGpPWpGaD
